TTC39B and atherosclerosis: TTC39B deficiency displayed increased HDL-cholesterol levels associated with increased enterocyte Abca1 expression, increased LXR protein, decreased fatty liver, decreased LDL levels, and reduced atherosclerosis (Hsieh et al., 2016).